XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jul. 01, 2023
Jul. 02, 2022
Operating Activities    
Net income $ 24,923 $ 45,042
Adjustments to reconcile net income to net cash provided by (used in) operating activities of continuing operations:    
Depreciation of property and equipment 12,441 10,561
Amortization of other intangible assets 12,904 19,194
Amortization of debt issuance costs 960 994
Loss on extinguishment of convertible debt   3
Stock-based compensation expense 31,377 27,264
Equity-method (earnings) loss 1,090 (1,166)
Deferred income taxes (6,403) (9,344)
Changes in operating assets and liabilities:    
Accounts receivable (26,819) 26,207
Inventories (45,064) (24,714)
Prepaid expenses and other assets 32,963 (25,286)
Accounts payable (30,003) 25,606
Other current liabilities and income taxes (26,220) (3,418)
Deferred revenue and returns liability 4,326 (3,153)
Other non-current liabilities (1,975) (4,416)
Net cash provided by (used in) operating activities of continuing operations (15,500) 83,374
Investing Activities    
Purchases of marketable securities (81,427) (554,267)
Sales of marketable securities 339,555 27,404
Maturities of marketable securities 171,691 511,296
Purchases of property and equipment (13,462) (12,322)
Purchases of other assets (215)  
Net cash provided by (used in) investing activities of continuing operations 416,142 (27,889)
Financing Activities    
Proceeds from revolving line of credit 80,000  
Payments on debt (536,124) (21)
Repurchases of common stock (201,095) (579,040)
Payment of taxes withheld for vested stock awards (16,310) (13,958)
Proceeds from the issuance of common stock 7,785 6,365
Net cash used in financing activities of continuing operations (665,744) (586,654)
Discontinued Operations    
Operating activities 0 (38,604)
Net cash used in discontinued operations 0 (38,604)
Decrease in cash and cash equivalents (265,102) (569,773)
Cash and cash equivalents at beginning of period 499,915 1,074,623
Cash and cash equivalents at end of period $ 234,813 $ 504,850